A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine
Conclusions:
Few studies have been conducted to evaluate the analgesic effects of AAs. The collective findings of multiple studies evaluating olanzapine in pain syndromes suggest a high, yet preliminary level of evidence of efficacy, warranting prospective studies in various pain syndrome contexts. Pharmacological mechanisms of AA action are elaborated, and the findings of this review are discussed. Risk and benefits of using AAs in chronic pain are described, and investigational implications and future directions are explored.
Source: The Clinical Journal of Pain - Category: Anesthesiology Tags: Review Articles Source Type: research
More News: Abilify | Anesthesiology | Chronic Pain | Databases & Libraries | Fibromyalgia | Geodon | Headache | Invega | Migraine | Pain | Pain Management | Risperdal Consta | Seroquel | Study | Ziprasidone | Zyprexa